LeWitt, P.A. et al. (2016) A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease. Movement Disorders, 31(9), pp. 1356-1365. (doi: 10.1002/mds.26611) (PMID:27090868)
|
Text
191374.pdf - Published Version Available under License Creative Commons Attribution. 478kB |
Abstract
Although levodopa is the most effective oral PD therapy, many patients experience motor fluctuations, including sudden loss of dose effect and delayed benefit. CVT-301 is a levodopa inhalation powder with the potential for rapid onset of action. The objective of this study was to evaluate CVT-301 self-administered by PD patients to relieve OFF episodes.PD patients with ≥2 hours per day of OFF time despite oral levodopa ≥4 times per day were randomized to CVT-301 or placebo for 4 weeks, to be used up to 3 times per day for OFF episodes. After 2 weeks, the study-drug dose was escalated from 35 to 50 mg. The primary end point was mean change in UPDRS Part III score from a predose OFF state to the average of postdose scores obtained at 10, 20, 30, and 60 minutes, as assessed in-clinic at the end of week 4. Home diaries were recorded.Eighty-six patients used the study drug at an average frequency of 2.1 times per day for CVT-301 and for placebo. At 4 weeks, least-squares mean change in UPDRS Part III score favored CVT-301 by 7.0 points (P < 0.001). A treatment effect was evident at 10 minutes. At 4 weeks, least-squares mean OFF-time change from baseline favored CVT-301 by 0.9 hours per day (P = 0.045). The most frequently reported adverse events in the CVT-301 group were dizziness, cough, and nausea, each in 7% (3 of 43 patients).CVT-301 self-administered during OFF episodes provided rapid improvement of motor function, and daily OFF time was significantly reduced at the higher dose. CVT-301 was generally safe and well-tolerated.
Item Type: | Articles |
---|---|
Additional Information: | Funding agencies:: This study was supported by Civitas, now wholly owned by Acorda Therapeutics. |
Status: | Published |
Refereed: | Yes |
Glasgow Author(s) Enlighten ID: | Grosset, Professor Donald |
Authors: | LeWitt, P.A., Hauser, R.A., Grosset, D.G., Stocchi, F., Saint-Hilaire, M.-H., Ellenbogen, A., Leinonen, M., Hampson, N.B., DeFeo-Fraulini, T., Freed, M.I., and Kieburtz, K.D. |
College/School: | College of Medical Veterinary and Life Sciences > School of Psychology & Neuroscience |
Journal Name: | Movement Disorders |
Publisher: | Wiley |
ISSN: | 0885-3185 |
ISSN (Online): | 1531-8257 |
Published Online: | 19 April 2016 |
Copyright Holders: | Copyright © 2016 The Authors |
First Published: | First published in Movement Disorders 31:1356-1365 |
Publisher Policy: | Reproduced under a creative commons licence |
Related URLs: |
University Staff: Request a correction | Enlighten Editors: Update this record